These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11489768)

  • 1. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients.
    Stone GW; Mehran R; Dangas G; Lansky AJ; Kornowski R; Leon MB
    Circulation; 2001 Aug; 104(6):642-7. PubMed ID: 11489768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myonecrosis after revascularization procedures.
    Califf RM; Abdelmeguid AE; Kuntz RE; Popma JJ; Davidson CJ; Cohen EA; Kleiman NS; Mahaffey KW; Topol EJ; Pepine CJ; Lipicky RJ; Granger CB; Harrington RA; Tardiff BE; Crenshaw BS; Bauman RP; Zuckerman BD; Chaitman BR; Bittl JA; Ohman EM
    J Am Coll Cardiol; 1998 Feb; 31(2):241-51. PubMed ID: 9462562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.
    Ramsay J; Shernan S; Fitch J; Finnegan P; Todaro T; Filloon T; Nussmeier NA
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):300-6. PubMed ID: 15678039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implication of creatine kinase elevation following elective coronary artery interventions.
    Kong TQ; Davidson CJ; Meyers SN; Tauke JT; Parker MA; Bonow RO
    JAMA; 1997 Feb; 277(6):461-6. PubMed ID: 9020269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.
    Jeremias A; Baim DS; Ho KK; Chauhan M; Carrozza JP; Cohen DJ; Popma JJ; Kuntz RE; Cutlip DE
    J Am Coll Cardiol; 2004 Sep; 44(6):1210-4. PubMed ID: 15364321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).
    Harrington RA; Lincoff AM; Califf RM; Holmes DR; Berdan LG; O'Hanesian MA; Keeler GP; Garratt KN; Ohman EM; Mark DB
    J Am Coll Cardiol; 1995 Jun; 25(7):1693-9. PubMed ID: 7759725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
    Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
    J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
    Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
    J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes.
    Fuchs S; Gruberg L; Singh S; Stabile E; Duncan C; Wu H; Waksman R; Satler LF; Pichard AD; Kent KM; Kornowski R
    Am J Cardiol; 2001 Jul; 88(2):129-33. PubMed ID: 11448408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft.
    Leborgne L; Cheneau E; Pichard A; Ajani A; Pakala R; Yazdi H; Satler L; Kent K; Suddath WO; Pinnow E; Canos D; Waksman R
    Am Heart J; 2003 Sep; 146(3):501-6. PubMed ID: 12947370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.
    Kornowski R; Fuchs S; Hong MK; Mehran R; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
    Catheter Cardiovasc Interv; 2000 Oct; 51(2):131-7. PubMed ID: 11025563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis.
    Ajani AE; Waksman R; Sharma AK; Lew R; Pinnow E; Canos DA; Cheneau E; Castagna M; Cha DH; Leborgne L; Satler LF; Pichard AD; Kent KM; Lindsay J
    Am J Cardiol; 2004 Feb; 93(3):313-7. PubMed ID: 14759380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation.
    Ricciardi MJ; Wu E; Davidson CJ; Choi KM; Klocke FJ; Bonow RO; Judd RM; Kim RJ
    Circulation; 2001 Jun; 103(23):2780-3. PubMed ID: 11401931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?
    Akkerhuis KM; Alexander JH; Tardiff BE; Boersma E; Harrington RA; Lincoff AM; Simoons ML
    Circulation; 2002 Feb; 105(5):554-6. PubMed ID: 11827918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.